x_AdministeredSubstance - HL7 Terminology (THO) v7.1.0

HL7 Terminology (THO)
7.1.0 - Continuous Process Integration (ci build) International flag

HL7 Terminology (THO), published by HL7 International - Vocabulary Work Group. This guide is not an authorized publication; it is the continuous build for version 7.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions

ValueSet: x_AdministeredSubstance

Official URL: http://terminology.hl7.org/ValueSet/v3-xAdministeredSubstance	Version: 3.0.0	Highlight text changes?
	Responsible: Health Level Seven International	Computable Name: XAdministeredSubstance
Other Identifiers: OID:2.16.840.1.113883.1.11.19667
Copyright/Legal: This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html

A type of Manufactured Material that is administered to a living subject, either by a healthcare professional or auto-administered, within a healthcare context.

References

Included into EntityCode

Logical Definition (CLD)

Language: en

This value set includes codes based on the following rules:

Include these codes as defined in http://terminology.hl7.org/CodeSystem/v3-EntityCode version 📦4.0.0
Code Display Definition
VCCNE Vaccine A Type of medicine that creates an immune protection without the recipient experiencing the disease.
Import all the codes that are contained in x_Medicine

Expansion

Expansion performed internally based on:

This value set contains 2 concepts

System	Code	Display (en)	Definition	JSON	XML
`http://terminology.hl7.org/CodeSystem/v3-EntityCode`	VCCNE	Vaccine	A Type of medicine that creates an immune protection without the recipient experiencing the disease.
`http://terminology.hl7.org/CodeSystem/v3-EntityCode`	BLDPRD	Blood Product	A manufactured product that is produced from the raw blood oi a donor with the intention of using it in a recipient transfusion.